Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FTO | Q9C0B1 | 8/20 | 0.52 |
| ▸ | MAPT | P10636 | 4/20 | 0.52 |
| ▸ | MEN1 | O00255 | 3/20 | 0.52 |
| ▸ | HTT | P42858 | 3/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.52 |
| ▸ | HPGD | P15428 | 2/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | RECQL | P46063 | 1/20 | 0.52 |
| ▸ | BLM | P54132 | 1/20 | 0.52 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.52 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.52 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6738373 | 1.00 | FTO (0.52) | FTOMAPTMEN1HTTKMT2A | |
| SCHEMBL622479 | 0.96 | FTO (0.54) | FTOMAPTMEN1HTTKMT2A | |
| SCHEMBL16116120 | 0.89 | FTO (0.54) | FTOMAPTMEN1HTTKMT2A | |
| SCHEMBL6888031 | 0.88 | FTO (0.41) | FTOMAPTMEN1HTTKMT2A | |
| SCHEMBL8196841 | 0.88 | FTO (0.48) | FTOMAPTMEN1HTTKMT2A | |
| SCHEMBL3788322 | 0.88 | FTO (0.48) | FTOMAPTMEN1HTTKMT2A | |
| SCHEMBL3694702 | 0.88 | FTO (0.51) | FTOMAPTMEN1HTTKMT2A | |
| SCHEMBL2314510 | 0.87 | FTO (0.60) | FTOMAPTMEN1HTTKMT2A | |
| SCHEMBL4824384 | 0.87 | FTO (0.54) | FTOMAPTMEN1HTTKMT2A | |
| SCHEMBL9192235 | 0.84 | FTO (0.49) | FTOMAPTMEN1HTTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6524242-B2 | Non-contact method for measuring amount of sebum or oil on substrate in real time using fluorescence dye | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2003-02-25 | — | — | US | claimed |
| US-20030004404-A1 | NON-CONTACT METHOD FOR MEASURING AMOUNT OF SEBUM OR OIL ON SUBSTRATE IN REAL TIME USING FLUORESCENCE DYE | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2003-01-02 | — | — | US | claimed |
| CN-109867683-B | Triazolyl benzaldehyde fluorescein hydrazide Schiff base and preparation method thereof | 齐鲁工业大学 | 2021-08-10 | — | — | CN | disclosed |
| CN-112390805-A | Benzimidazole benzaldehyde fluorescein hydrazide Schiff base and preparation method thereof | 齐鲁工业大学 | 2021-02-23 | — | — | CN | disclosed |
| US-10180424-B2 | Enhancement solution for enhancing chemiluminescence and method for preparing chemiluminescent solution | SHENZHEN MAXCHEMTECH CO., LTD. (CN) | 2019-01-15 | — | — | US | disclosed |
| US-20170016887-A1 | ENHANCEMENT SOLUTION FOR ENHANCING CHEMILUMINESCENCE AND METHOD FOR PREPARING CHEMILUMINESCENT SOLUTION | SHENZHEN MAXCHEMTECH CO., LTD. (CN) | 2017-01-19 | — | — | US | disclosed |
| CN-104597233-B | Liquid and the method for preparing chemical luminescence for liquid is strengthened for enhanced chemiluminescence | 深圳市美凯特科技有限公司 | 2016-09-14 | — | — | CN | disclosed |
| CN-104597233-A | Enhancement solution for chemiluminiscence enhancement and chemiluminescent solution preparation method | SHENZHEN MAXCHEMTECH CO LTD | 2015-05-06 | — | — | CN | disclosed |
| US-20130211043-A1 | METHOD FOR PREVENTING HIV-1 INFECTION OF CD4+ CELLS | CYTODYN, INC. (US) | 2013-08-15 | — | — | US | disclosed |
| US-7935797-B2 | Contacting with monoclonal antibody which binds to chemokine receptor; blocks fusion and inhibits activation of inflammatory response | PROGENICS PHARMACEUTICALS INC. (US) | 2011-05-03 | — | — | US | disclosed |
| EP-1998812-B1 | METHOD TO ASSESS SURFACTANT ADSORPTION ON SKIN | UNILEVER PLC (GB) | 2011-04-13 | — | — | EP | disclosed |
| WO-1998056421-A1 | METHOD FOR PREVENTING HIV-1 INFECTION OF CD4+ CELLS | PROGENICS PHARMACEUTICALS, INC. (US) | 1998-12-17 | — | — | WO | disclosed |
| EP-0847452-A1 | FLUORESCENCE RESONANCE ENERGY TRANSFER SCREENING ASSAY FOR THE IDENTIFICATION OF HIV-1 ENVELOPE GLYCOPROTEIN-MEDICATED CELL | PROGENICS PHARMACEUTICALS, INC. (US) | 1998-06-17 | — | — | EP | disclosed |
| WO-1997047318-A1 | USES OF A CHEMOKINE RECEPTOR FOR INHIBITING HIV-1 INFECTION | PROGENICS PHARMACEUTICALS, INC. (US) | 1997-12-18 | — | — | WO | disclosed |
| WO-1997047319-A1 | USES OF A CHEMOKINE RECEPTOR FOR INHIBITING HIV-1 INFECTION | PROGENICS PHARMACEUTICALS, INC. (US) | 1997-12-18 | — | — | WO | disclosed |
| WO-1997037005-A1 | METHOD FOR PREVENTING HIV-1 INFECTION OF CD4+ CELLS | PROGENICS PHARMACEUTICALS, INC. (US) | 1997-10-09 | — | — | WO | disclosed |
| WO-1997026009-A1 | COMPOUNDS CAPABLE OF INHIBITING HIV-1 INFECTION | PROGENICS PHARMACEUTICALS, INC. (US) | 1997-07-24 | — | — | WO | disclosed |
| WO-1996041020-A1 | FLUORESCENCE RESONANCE ENERGY TRANSFER SCREENING ASSAY FOR THE IDENTIFICATION OF HIV-1 ENVELOPE GLYCOPROTEIN-MEDICATED CELL | PROGENICS PHARMACEUTICALS, INC. (US) | 1996-12-19 | — | — | WO | disclosed |
| EP-0738330-A1 | METHODS FOR USING RESONANCE ENERGY TRANSFER-BASED ASSAY OF HIV-1 ENVELOPE CLYCOPROTEIN-MEDIATED MEMBRANE FUSION, AND KITS FOR PRACTICING SAME | PROGENICS PHARMACEUTICALS, INC. (US) | 1996-10-23 | — | — | EP | disclosed |
| WO-1995016789-A1 | METHODS FOR USING RESONANCE ENERGY TRANSFER-BASED ASSAY OF HIV-1 ENVELOPE CLYCOPROTEIN-MEDIATED MEMBRANE FUSION, AND KITS FOR PRACTICING SAME | PROGENICS PHARMACEUTICALS, INC. (US) | 1995-06-22 | — | — | WO | disclosed |